279 related articles for article (PubMed ID: 33199252)
1. Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma.
Bandini M; Ross JS; Zhu Y; Ye DW; Ornellas AA; Watkin N; Ayres BA; Hakenberg OW; Heidenreich A; Salvioni R; Catanzaro M; Raggi D; Giannatempo P; Marandino L; Haidl F; Pederzoli F; Briganti A; Montorsi F; Chipollini J; Azizi M; De Meerleer G; Brouwer OR; Grass GD; Johnstone PA; Albersen M; Spiess PE; Necchi A
Eur Urol Oncol; 2021 Oct; 4(5):802-810. PubMed ID: 33199252
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI; Ryan CJ; McKay RR; Master VA; Bilen MA
Cancer; 2023 Dec; 129(24):3884-3893. PubMed ID: 37565840
[TBL] [Abstract][Full Text] [Related]
4. Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel.
Robinson R; Marconi L; MacPepple E; Hakenberg OW; Watkin N; Yuan Y; Lam T; MacLennan S; Adewuyi TE; Coscione A; Minhas SS; Compérat EM; Necchi A
Eur Urol; 2018 Jul; 74(1):76-83. PubMed ID: 29703686
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy.
Wei L; Li Z; Guo S; Ma H; Shi Y; An X; Huang K; Xiong L; Xue T; Zhang Z; Yao K; Luo J; Han H
Cancer; 2024 May; 130(9):1650-1662. PubMed ID: 38157276
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies.
Chakiryan NH; Dahmen A; Bandini M; Pederzoli F; Marandino L; Albersen M; Roussel E; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Chahoud J; Briganti A; Salvioni R; Montorsi F; Necchi A; Spiess PE
J Urol; 2021 Oct; 206(4):960-969. PubMed ID: 34032492
[TBL] [Abstract][Full Text] [Related]
7. Management of the lymph nodes in penile cancer.
Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
[TBL] [Abstract][Full Text] [Related]
8. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.
Werntz RP; Riedinger CB; Fantus RJ; Smith ZL; Packiam VT; Adamsky MA; Smith N; Steinberg GD
Urol Oncol; 2018 Dec; 36(12):526.e1-526.e6. PubMed ID: 30446445
[TBL] [Abstract][Full Text] [Related]
9. Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years.
Moen CA; Falkenthal TE; Thorkelsen TK; Hopland A; Rio OE; Honoré A; Juliebø-Jones P; Dongre HN; Costea DE; Bostad L; Brennan P; Johansson M; Ferreiro-Iglesias A; Brenner N; Waterboer T; Nygård M; Beisland C
Eur Urol Oncol; 2023 Nov; ():. PubMed ID: 37949729
[TBL] [Abstract][Full Text] [Related]
10. Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter study.
Necchi A; Lo Vullo S; Mariani L; Zhu Y; Ye DW; Ornellas AA; Watkin N; Ager M; Hakenberg OW; Heidenreich A; Raggi D; Catanzaro M; Salvioni R; Chipollini J; Azizi M; Spiess PE
Urol Oncol; 2019 Aug; 37(8):531.e7-531.e15. PubMed ID: 31053524
[TBL] [Abstract][Full Text] [Related]
11. National trends and survival outcomes of penile squamous cell carcinoma based on human papillomavirus status.
Chipollini J; Pollock G; Hsu CH; Batai K; Recio-Boiles A; Lee BR
Cancer Med; 2021 Nov; 10(21):7466-7474. PubMed ID: 34632731
[TBL] [Abstract][Full Text] [Related]
12. Immune landscape and immunotherapy for penile cancer.
Tang Y; Hu X; Wu K; Li X
Front Immunol; 2022; 13():1055235. PubMed ID: 36524123
[TBL] [Abstract][Full Text] [Related]
13. Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments.
Elst L; Van Rompuy AS; Roussel E; Spans L; Vanden Bempt I; Necchi A; Ross J; Jacob JM; Baietti MF; Leucci E; Albersen M
Eur Urol Focus; 2022 Nov; 8(6):1787-1794. PubMed ID: 35537937
[TBL] [Abstract][Full Text] [Related]
14. Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes.
Johnstone PAS; Boulware D; Djajadiningrat R; Ottenhof S; Necchi A; Catanzaro M; Ye D; Zhu Y; Nicolai N; Horenblas S; Spiess PE
Eur Urol Focus; 2019 Sep; 5(5):737-741. PubMed ID: 30327282
[TBL] [Abstract][Full Text] [Related]
15. Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancer.
Ball MW; Schwen ZR; Ko JS; Meyer A; Netto GJ; Burnett AL; Bivalacqua TJ
Investig Clin Urol; 2017 Jan; 58(1):20-26. PubMed ID: 28097264
[TBL] [Abstract][Full Text] [Related]
16. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization.
Elst L; Philips G; Vandermaesen K; Bassez A; Lodi F; Vreeburg MTA; Brouwer OR; Schepers R; Van Brussel T; Mohanty SK; Parwani AV; Spans L; Vanden Bempt I; Jacomen G; Baldewijns M; Lambrechts D; Albersen M
Eur Urol; 2024 Apr; ():. PubMed ID: 38670879
[TBL] [Abstract][Full Text] [Related]
17. Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer.
Soodana-Prakash N; Koru-Sengul T; Miao F; Lopategui DM; Savio LF; Moore KJ; Johnson TA; Alameddine M; Barboza MP; Parekh DJ; Punnen S; Gonzalgo ML; Ritch CR
Urol Oncol; 2018 Oct; 36(10):471.e19-471.e27. PubMed ID: 30143385
[TBL] [Abstract][Full Text] [Related]
18. Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis.
Ferrándiz-Pulido C; Masferrer E; de Torres I; Lloveras B; Hernandez-Losa J; Mojal S; Salvador C; Morote J; Ramon y Cajal S; Pujol RM; Garcia-Patos V; Toll A
J Am Acad Dermatol; 2013 Jan; 68(1):73-82. PubMed ID: 22863066
[TBL] [Abstract][Full Text] [Related]
19. Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational Burden.
Necchi A; Spiess PE; Costa de Padua T; Li R; Grivas P; Huang RSP; Lin DI; Danziger N; Ross JS; Jacob JM; Sager RA; Basnet A; Li G; Graf RP; Pavlick DC; Bratslavsky G
JAMA Netw Open; 2023 Dec; 6(12):e2348002. PubMed ID: 38150257
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma.
Chakiryan NH; Dahmen A; Bandini M; Pederzoli F; Marandino L; Albersen M; Roussel E; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Briganti A; Salvioni R; Montorsi F; Necchi A; Spiess PE
Urol Oncol; 2021 Dec; 39(12):838.e7-838.e13. PubMed ID: 34602362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
